Today: 10 June 2026
Marvell Technology stock slips after insider sale filing; AI deal digested as CPI looms
10 January 2026
1 min read

Marvell Technology stock slips after insider sale filing; AI deal digested as CPI looms

NEW YORK, Jan 9, 2026, 21:00 EST — Market closed.

  • Marvell slipped 0.3% on Friday, dragging its loss to roughly 8% since Monday’s close
  • According to an SEC filing, Marvell’s chief legal officer offloaded 5,000 shares
  • Traders are focusing on next week’s U.S. CPI report and Marvell’s earnings due in early March as the upcoming catalysts

Marvell Technology (MRVL.O) shares slipped 0.3% on Friday following a filing revealing a stock sale by a top executive. The chipmaker has tumbled sharply since earlier this week, transforming what started as a deal-fueled rebound into fresh volatility.

These shifts matter since Marvell is deep in the data-center expansion, providing custom AI chips and networking silicon that shuttles data between servers. Investors remain uneasy about whether major cloud clients will maintain their spending pace, so Marvell’s order updates often trigger sharp stock moves.

JPMorgan analyst Harlan Sur reported that Chairman and CEO Matt Murphy described near-term AI bookings as “on fire” in a recent fireside chat. Management expects data-center growth to hit about 25% in calendar 2026, with acceleration projected for 2027. Sur also highlighted management’s forecast for custom AI revenue around $1.8 billion in 2026, doubling to roughly $3.6 billion in 2027. Benzinga

Marvell ended the day at $83.22, slipping roughly 25 cents from its previous close, market data show.

Technicians are keeping an eye on whether the stock can maintain support around the low $82 level after Friday’s intraday dip near $82, following a peak closer to the mid-$90s earlier in the week’s selloff.

A Form 4 submitted on Jan. 7 revealed that EVP and Chief Legal Officer Mark Casper sold 5,000 Marvell shares on Jan. 5 at $93.08 each. After the sale, he retained 19,418 shares directly, along with more shares held via a family trust.

Earlier this week, Marvell announced plans to acquire networking equipment maker XConn Technologies for roughly $540 million, aiming to strengthen its AI data-center connectivity segment. CEO Matt Murphy described the deal as creating “a compelling switching platform,” highlighting the silicon technology that manages traffic routing in data centers. Reuters

Friday marked Marvell’s ex-dividend date for a $0.06 quarterly payout scheduled for Jan. 29, creating a minor technical factor for short-term traders. Looking ahead to Monday, macro investors are focused on the upcoming U.S. inflation data — the December 2025 CPI report is set for release on Jan. 13 — while rate forecasts remain influenced by the Federal Reserve’s policy meeting on Jan. 27–28.

That downside risk remains. If cloud clients pull back on orders, or if competitors such as Broadcom (AVGO.O) and Nvidia (NVDA.O) strengthen their hold on data-center networking and AI infrastructure, Marvell’s outlook could come under pressure, leaving the stock volatile.

Marvell is set to release earnings on March 4, per Nasdaq data, with investors zeroing in on data-center guidance and any news about the XConn integration timeline.

Stock Market Today

  • Palantir Technologies (PLTR) Shares Seen Fairly Valued Amid Recent Decline
    June 10, 2026, 5:48 PM EDT. Palantir Technologies has seen its share price fall 13.2% over the past week and 21.3% year to date, following extraordinary gains in prior years. At $132.07 per share, Palantir trades slightly below its estimated intrinsic value of $145.11 based on a Discounted Cash Flow (DCF) analysis, suggesting a modest 9% discount. The company posted $2.69 billion in free cash flow over the past twelve months, with projections rising to $16.11 billion by 2030. Despite recent volatility tied to sentiment on artificial intelligence and software spending, Palantir remains fairly valued but not a clear bargain. Investors should monitor further market developments and valuation metrics to gauge future opportunities or risks.

Latest articles

Parabilis Medicines (PBLS) soars 58% after $670 million IPO beats range

Parabilis Medicines (PBLS) soars 58% after $670 million IPO beats range

10 June 2026
Parabilis Medicines soared 58% above its $20 IPO price to close at $31.60 in its Nasdaq debut after raising a record $670 million, reflecting strong investor demand for its Helicon drug platform ahead of a pivotal Phase 3 desmoid tumor trial planned for 2027; Regeneron’s $75 million private placement added credibility.
Joby Aviation Shares Slip After CFO Files to Sell Stock

Joby Aviation Shares Slip After CFO Files to Sell Stock

10 June 2026
Joby Aviation fell 4.47% to $8.86 after CFO Rodrigo Brumana disclosed selling 78,489 shares under a prearranged 10b5-1 plan, with no new certification or commercial-launch updates, leaving investors focused on regulatory progress and cash burn as the key catalysts for the stock.
YY Group Shares Spike as Humanoid Robot Plans Unveiled

YY Group Shares Spike as Humanoid Robot Plans Unveiled

10 June 2026
YY Group Holding shares surged to $0.165 on heavy volume after announcing a commercial humanoid-robotics initiative using Unitree G1 robots and facility-management data, reframing the company as a robotics-and-AI data play; the rally comes despite 2025 net loss, dilution risk from a relaunched at-the-market share-sale program, and no disclosed robot-related revenue or contracts.
Adobe stock slides on BMO downgrade: “no clear catalyst” and competition in focus
Previous Story

Adobe stock slides on BMO downgrade: “no clear catalyst” and competition in focus

Lloyds share price clings to £1 as investors eye inflation data and Jan 29 results
Next Story

Lloyds share price clings to £1 as investors eye inflation data and Jan 29 results

Go toTop